Body Composition in Patients with Ankylosing Spondylitis on Anti-Tumor Necrosis Factor Alpha Treatment

Basit Öğe Kaydı
dc.contributor.authorSahin, Ozlem
dc.contributor.authorKaptanoglu, Ece
dc.contributor.authorDinler, Mustafa
dc.contributor.authorDogan, Sevil Ceyhan
dc.contributor.authorKurt, Kibar Gultekin
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T09:41:06Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T09:41:06Z
dc.date.issued2017
dc.department[Sahin, Ozlem -- Dinler, Mustafa -- Dogan, Sevil Ceyhan] Cumhuriyet Univ, Fac Med, Dept Phys Med & Rehabil, TR-58141 Sivas, Turkey -- [Kaptanoglu, Ece] Cumhuriyet Univ, Fac Med, Dept Phys Med & Rehabil, Div Rheumatol, Sivas, Turkey -- [Kurt, Kibar Gultekin] Cumhuriyet Univ, Training & Res Hosp, Sivas, Turkeyen_US
dc.description.abstractObjectives: To examine the body composition (BC) of the Ankylosing spondylitis (AS) patients on anti-TNF therapy and to evaluate the clinical parameters in obese AS patients Design: Cross-sectional case-control study Setting: Department of Physical Medicine and Rehabilitation, Cumhuriyet University, Medical Faculty, Sivas, Turkey Subjects: Thirty-four AS patients and 34 healthy subjects as controls were included in the study between November 2014 and May 2015 Main outcome measures: Waist circumference (WC), body mass index (BMI), percent body fat (PBF), fat mass (FM) and fat free mass (FFM) were measured in patients and control group. In AS group, disease activity, functional status, spinal mobility and life quality were examined by standard AS questionnaires. Results: WC, BMI, PBF, FM, and FFM were comparable in AS patients and controls. There was a positive correlation between the duration of the anti-TNF treatment and BMI (p = 0.02, r = 0.409). In obese AS patients, the duration of the anti-TNF treatment was significantly longer than the normal weight AS patients (for BMI p = 0.02, for PBF p = 0.03). Obese and normal weight AS patients were comparable regarding disease duration, disease activity, functional status, spinal mobility and life quality. Conclusions: The BC of AS patients on anti-TNF treatment was similar to healthy controls. Anti-TNF treatment has comparable effects on disease parameters in both the normal weight and obese AS patients. Long-term treatment with anti-TNF drugs may lead to obesity. Prospective controlled studies with more patients to clarify this probable effect of anti-TNF drugs are required.en_US
dc.identifier.endpage147en_US
dc.identifier.issn0023-5776
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85019891698en_US
dc.identifier.scopusqualityN/A
dc.identifier.startpage142en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12418/6764
dc.identifier.volume49en_US
dc.identifier.wosWOS:000404556300008en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherKUWAIT MEDICAL ASSOCen_US
dc.relation.ispartofKUWAIT MEDICAL JOURNALen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectankylosing spondylitisen_US
dc.subjectanti-tumor necrosis factor treatmenten_US
dc.subjectbody compositionen_US
dc.subjectobesityen_US
dc.titleBody Composition in Patients with Ankylosing Spondylitis on Anti-Tumor Necrosis Factor Alpha Treatmenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu